永旺(00984.HK)與ADMC訂立資訊科技主協議
格隆匯7月31日丨永旺(00984.HK)公告,於2020年7月31日,公司與ADMC就提供該等服務訂立續訂資訊科技主協議。集團與ADMC於2017年8月30日至2017年12月31日期間、截至2019年12月31日止兩個年度以及截至2020年5月31日止5個月於資訊科技主協議項下的過往交易金額分別約為人民幣640萬元、人民幣1490萬元、人民幣2110萬元及人民幣830萬元。
董事認為,訂立續訂資訊科技主協議將會加強集團的整體資訊科技系統,從而提高集團的營運效率及降低成本。其亦將鞏固集團對客户提供的服務以及提高客户在集團的購物體驗感。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.